STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

Pulse Oximeter for Sleep Evaluation

Completed

Conditions: Obstructive Sleep Apnea

Interventions: Diagnostic Test: Belun Ring

First Posted Date: 2020-11-02

Last Posted Date: 2022-06-22

Lead Sponsor: Stanford University

Target Recruit Count: 40

Registration Number: NCT04612114

Locations: 🇺🇸
Stanford University, Redwood City, California, United States

Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery

Phase 1

Recruiting

Conditions: Gastroenteropancreatic Neuroendocrine Tumor

Interventions: Drug: Lutathera
Drug: Gallium 68 Dotatate
Procedure: Computed Tomography (CT)
Procedure: Magnetic Resonance Imaging (MRI)
Procedure: PET/CT

First Posted Date: 2020-10-30

Last Posted Date: 2024-10-28

Lead Sponsor: Stanford University

Target Recruit Count: 10

Registration Number: NCT04609592

Locations: 🇺🇸
Stanford Cancer Institute Palo Alto, Stanford, California, United States

Testing of Mobile Monitoring System

Not Applicable

Not yet recruiting

Conditions: Orthopedic Disorder

Interventions: Behavioral: Mobile Monitoring Tool

First Posted Date: 2020-10-23

Last Posted Date: 2023-11-22

Lead Sponsor: Stanford University

Target Recruit Count: 500

Registration Number: NCT04601376

Insul-In This Together Program for Adolescents With Type 1 Diabetes and Their Parents

Not Applicable

Active, not recruiting

Conditions: Type 1 Diabetes

Interventions: Behavioral: Insul-In This Together

First Posted Date: 2020-10-19

Last Posted Date: 2023-11-03

Lead Sponsor: Stanford University

Target Recruit Count: 314

Registration Number: NCT04589689

Locations: 🇺🇸
Stanford University, Stanford, California, United States

A Pharmacokinetic stuDy of intRavitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Diabetic Macular Edema

Phase 2

Withdrawn

Conditions: Diabetic Macular Edema

Interventions: Drug: Intravitreal Aflibercept

First Posted Date: 2020-10-19

Last Posted Date: 2022-04-28

Lead Sponsor: Stanford University

Registration Number: NCT04588948

Locations: 🇺🇸
Byers Eye Institute, Palo Alto, California, United States

Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)

Phase 2

Recruiting

Conditions: Non-small Cell Lung Cancer Stage II
Non-small Cell Lung Cancer
Non-small Cell Lung Cancer Stage I
Non-small Cell Lung Cancer Stage III

Interventions: Device: AVENIO ctDNA Surveillance Kit
Drug: Durvalumab

First Posted Date: 2020-10-14

Last Posted Date: 2024-12-24

Lead Sponsor: Stanford University

Target Recruit Count: 80

Registration Number: NCT04585477

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Recruiting

Conditions: Corona Virus Infection
Immunity
Flu Vaccine

Interventions: Biological: Flu shot

First Posted Date: 2020-10-08

Last Posted Date: 2024-11-04

Lead Sponsor: Stanford University

Target Recruit Count: 230

Registration Number: NCT04579588

Locations: 🇺🇸
Stanford University, Palo Alto, California, United States

Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma

Phase 2

Recruiting

Conditions: Glaucoma

Interventions: Drug: NT-501
Other: Sham comparator

First Posted Date: 2020-10-06

Last Posted Date: 2024-08-13

Lead Sponsor: Stanford University

Target Recruit Count: 30

Registration Number: NCT04577300

Locations: 🇺🇸
Byers Eye Institute at Stanford University, Palo Alto, California, United States

Pediatric Source Control for Hazardous Particulate Exposure in Aerosol Generating Procedures

Not Applicable

Not yet recruiting

Conditions: Risk Reduction

Interventions: Device: Disposable oxygen face tent

First Posted Date: 2020-10-06

Last Posted Date: 2023-04-18

Lead Sponsor: Stanford University

Target Recruit Count: 26

Registration Number: NCT04577209

Locations: 🇺🇸
Lucile Packard Childrens Hospital, Stanford, California, United States

Kidney and Hematopoietic Cell Transplants Using a Regimen to Promote Hematopoietic Cell Engraftment

Phase 1

Conditions: Immune Tolerance

Interventions: Biological: Combined Deceased Donor Kidney and Hematopoietic Cell Transplants

First Posted Date: 2020-09-30

Last Posted Date: 2022-05-11

Lead Sponsor: Stanford University

Target Recruit Count: 30

Registration Number: NCT04571203

Locations: 🇺🇸
Stanford University, Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy